Matias Wilfredo R, Teng Jessica E, Hilaire Isabelle J, Harris Jason B, Franke Molly F, Ivers Louise C
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
Partners In Health, Boston, Massachusetts.
Am J Trop Med Hyg. 2017 Aug;97(2):436-442. doi: 10.4269/ajtmh.16-0407. Epub 2017 Jul 19.
Oral cholera vaccination was used as part of cholera control in Haiti, but the vaccine does not provide complete protection. We conducted secondary data analyses of a vaccine effectiveness study in Haiti to evaluate risk factors for cholera among cholera vaccine recipients. Individuals vaccinated against cholera that presented with acute watery diarrhea and had a stool sample positive for O1 were included as cases. Up to four vaccinated individuals who did not present for treatment of diarrhea were included as controls for each case, and matched by location of residence, enrollment time, and age. We evaluated sociodemographic characteristics and risk factors for cholera. Univariable and multivariable logistic regression were performed to identify risk factors for cholera among vaccinees. Thirty-three vaccine recipients with culture-confirmed cholera were included as cases. One-hundred-and-seventeen of their matched controls reported receiving vaccine and were included as controls. In a multivariable analysis, self-reporting use of branded household water disinfection products as a means of treating water (adjusted relative risk [aRR] = 44.3, 95% confidence interval [CI] = 4.19-468.05, = 0.002), and reporting having a latrine as the main household toilet (aRR = 4.22, 95% CI = 1.23-14.43, = 0.02), were independent risk factors for cholera. Self-reporting always treating water (aRR = 0.09, 95% CI = 0.01-0.57, = 0.01) was associated with protection against cholera. The field effectiveness of water, sanitation, and hygiene interventions used in combination with cholera vaccination in cholera control should be measured and monitored over time to identify and remediate shortcomings, and ensure successful impact on disease control.
口服霍乱疫苗被用作海地霍乱控制措施的一部分,但该疫苗并不能提供完全的保护。我们对海地一项疫苗效力研究进行了二次数据分析,以评估霍乱疫苗接种者中霍乱的危险因素。接种霍乱疫苗且出现急性水样腹泻且粪便样本O1阳性的个体被纳入病例组。每例病例最多纳入四名未因腹泻就诊的接种个体作为对照组,并按居住地点、入组时间和年龄进行匹配。我们评估了霍乱的社会人口学特征和危险因素。进行单变量和多变量逻辑回归以确定疫苗接种者中霍乱的危险因素。33名经培养确诊霍乱的疫苗接种者被纳入病例组。他们的117名匹配对照组报告接种了疫苗并被纳入对照组。在多变量分析中,自我报告使用品牌家用饮用水消毒产品作为处理水的方式(调整相对风险[aRR]=44.3,95%置信区间[CI]=4.19-468.05,P=0.002),以及报告有厕所作为主要家庭卫生间(aRR=4.22,95%CI=1.23-14.43,P=0.02),是霍乱的独立危险因素。自我报告总是处理水(aRR=0.09,95%CI=0.01-0.57,P=0.01)与霍乱疫苗联合使用的水、环境卫生和个人卫生干预措施在霍乱控制中的现场效果应随着时间的推移进行测量和监测,以识别和纠正不足之处,并确保对疾病控制产生成功影响。